▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for TapImmune in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $8.34.
The current consensus among 0 polled investment analysts is to n/a stock in TapImmune. This rating has held steady since May 2019, when it changed from a Buy consensus rating.